180 related articles for article (PubMed ID: 16466442)
1. Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection.
Hamad M; Muta'eb E; Abu-Shaqra Q; Fraij A; Abu-Elteen K; Yasin SR
Mycoses; 2006 Mar; 49(2):104-8. PubMed ID: 16466442
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-dependent induction of persistent vaginal candidosis in naïve mice.
Hamad M; Abu-Elteen KH; Ghaleb M
Mycoses; 2004 Aug; 47(7):304-9. PubMed ID: 15310335
[TBL] [Abstract][Full Text] [Related]
3. Persistent colonization and transient suppression of DTH responses in an estrogen-dependent vaginal candidosis murine model.
Hamad M; Abu-Elteen KH; Ghaleb M
New Microbiol; 2002 Jan; 25(1):65-73. PubMed ID: 11837393
[TBL] [Abstract][Full Text] [Related]
4. Acute vaginal candidosis model in the immunocompromized rat to evaluate delivery systems for antimycotics.
Foldvari M; Radhi J; Yang G; He Z; Rennie R; Wearley L
Mycoses; 2000; 43(11-12):393-401. PubMed ID: 11204356
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
[TBL] [Abstract][Full Text] [Related]
6. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Zhang H; Wang K; Zhang G; Ho HI; Gao A
Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
[TBL] [Abstract][Full Text] [Related]
8. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
[TBL] [Abstract][Full Text] [Related]
9. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
Liao H; Liu S; Wang H; Su H; Liu Z
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
[TBL] [Abstract][Full Text] [Related]
11. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
[TBL] [Abstract][Full Text] [Related]
12. The Lactobacilli--Candida relationship in cervico-vaginal smears.
Demirezen S
Cent Eur J Public Health; 2002 Sep; 10(3):97-9. PubMed ID: 12298349
[TBL] [Abstract][Full Text] [Related]
13. Effects of tigecycline and daptomycin on murine gut colonization by Candida albicans.
Samonis G; Mantadakis E; Barbounakis E; Kofteridis D; Papadakis G; Sifaki L; Maraki S
Mycoses; 2008 Jul; 51(4):324-7. PubMed ID: 18855845
[TBL] [Abstract][Full Text] [Related]
14. Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice.
Maruyama N; Takizawa T; Ishibashi H; Hisajima T; Inouye S; Yamaguchi H; Abe S
Biol Pharm Bull; 2008 Aug; 31(8):1501-6. PubMed ID: 18670079
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human mannose binding lectin alone and in combination with itraconazole against murine Candida albicans vaginitis.
Clemons KV; Martinez M; Axelsen M; Thiel S; Stevens DA
Immunol Invest; 2011; 40(6):553-68. PubMed ID: 21510780
[TBL] [Abstract][Full Text] [Related]
16. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Candida albicans in vaginal fluid of asymptomatic Portuguese women.
de Oliveira JM; Cruz AS; Fonseca AF; Vaz CP; Rodrigues A; Aurea F; Maia J; Sousa JA
J Reprod Med; 1993 Jan; 38(1):41-2. PubMed ID: 8441130
[TBL] [Abstract][Full Text] [Related]
19. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring?
Chassot F; Camacho DP; Patussi EV; Donatti L; Svidzinski TI; Consolaro ME
Contraception; 2010 Apr; 81(4):331-5. PubMed ID: 20227551
[TBL] [Abstract][Full Text] [Related]
20. Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis.
Ghaleb M; Hamad M; Abu-Elteen KH
Clin Exp Immunol; 2003 Jan; 131(1):26-33. PubMed ID: 12519382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
